Novel electrocardiographic screening criterion for hypertrophic cardiomyopathy in children

Matthew B Brothers1, Matthew E Oster1, Alexandra Ehrlich1

  • 1Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia.

Insights

A new pediatric-specific electrocardiogram criterion (RaVL+SV2) is more accurate for identifying hypertrophic cardiomyopathy (HC) in children than existing methods. This specialized tool enhances early detection of pediatric HC.

Area of Science:

  • Cardiology
  • Pediatrics
  • Medical Diagnostics

Background:

  • Electrocardiography (ECG) is frequently used to screen children for hypertrophic cardiomyopathy (HC).
  • Existing ECG criteria for left ventricular hypertrophy and HC may not be optimal for pediatric populations.
  • There is a need for a more accurate ECG screening tool tailored for children.

Purpose of the Study:

  • To develop and validate a pediatric-specific ECG criterion for identifying HC in children.
  • To compare the diagnostic accuracy of this new criterion against established ECG screening algorithms.

Main Methods:

  • Retrospective review of ECGs from 108 children with HC (ages 7-21) and age/gender-matched controls.
  • Evaluation of four ECG screening algorithms: Sokolow-Lyon, Cornell, total 12-lead voltage, and a novel pediatric-specific criterion (RaVL+SV2).
  • Comparison of diagnostic accuracy using receiver operating characteristic (ROC) curve analysis.

Main Results:

  • All four criteria showed statistically significant correlations with HC.
  • The pediatric-specific criterion (AUC 0.82) and total 12-lead voltage criterion (AUC 0.83) demonstrated higher accuracy than Sokolow-Lyon (AUC 0.67) and Cornell (AUC 0.70).
  • The pediatric-specific criterion exhibited superior sensitivity in gene-positive children and better overall specificity compared to the total 12-lead criterion.

Conclusions:

  • The pediatric-specific ECG criterion (RaVL+SV2) is more accurate for identifying hypertrophic cardiomyopathy in children.
  • This specialized criterion offers improved diagnostic performance over widely used screening methods.
  • The findings support the use of this tailored approach for enhanced pediatric HC screening.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
9.8K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790